Dixit, Deepali <br/><br/>
Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting?  [electronic resource] 

 -  BMJ case reports  Jul 2013 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1757-790X 
<br/><br/><label>Standard No.: </label>10.1136/bcr-2013-010133  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--adverse effects<br/>Critical Care<br/>Delirium--drug therapy<br/>Haloperidol--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuroleptic Malignant Syndrome--etiology